In a 13-year-old child presenting with a diffuse maculopapular rash and prominent posterior cervical and post‑auricular lymphadenopathy, what is the most likely diagnosis and appropriate management?

Rubella (German Measles) is the Most Likely Diagnosis

In a 13-year-old child presenting with maculopapular rash and prominent posterior cervical plus post-auricular lymphadenopathy, rubella is the most likely diagnosis and requires immediate isolation, serologic confirmation, and public health notification. 1

Clinical Presentation Strongly Supports Rubella

• Posterior auricular and suboccipital (posterior cervical) lymphadenopathy are pathognomonic features of rubella, distinguishing it from other viral exanthems. 1, 2
• The maculopapular rash in rubella classically begins on the face and spreads cephalocaudally, becoming generalized within 24 hours and typically disappearing within 3 days. 3
• Rubella characteristically presents with transient erythematous and sometimes pruritic rash, postauricular or suboccipital lymphadenopathy, arthralgia, and low-grade fever. 1
• The lymphadenopathy typically appears before the rash develops and is a key diagnostic clue. 1

Critical Differential Diagnoses to Exclude First

Rocky Mountain Spotted Fever (Must Rule Out)

• RMSF carries a 5-10% case-fatality rate with 50% of deaths occurring within 9 days of illness onset, making it the most dangerous differential. 4
• However, RMSF is unlikely here because the rash typically begins on ankles, wrists, or forearms 2-4 days after fever onset and progresses to involve palms and soles while sparing the face—the opposite distribution pattern of rubella. 4, 5
• RMSF rash evolves to maculopapular with central petechiae by days 5-6, which is not described in this case. 4
• The prominent lymphadenopathy pattern (posterior cervical and post-auricular) is not characteristic of RMSF. 4

Measles (Rubeola)

• Measles presents with pathognomonic Koplik spots (white spots on buccal mucosa), high fever, cough, coryza, and conjunctivitis—the "3 Cs"—before the rash appears. 6, 7
• The measles rash is more confluent and begins on the face, spreading cephalocaudally, but the lymphadenopathy pattern differs from rubella. 6
• Without the prodromal symptoms of cough, coryza, and conjunctivitis, measles is less likely. 6

Epstein-Barr Virus (Infectious Mononucleosis)

• EBV typically causes follicular conjunctivitis, generalized fatigue, pharyngitis, and generalized lymphadenopathy (not specifically posterior auricular/cervical). 1
• The rash in EBV is often triggered by ampicillin or amoxicillin administration. 4

Diagnostic Workup

Immediate Laboratory Testing

• Obtain rubella-specific IgM antibody serology immediately—a positive result confirms acute rubella infection. 3
• Four-fold or greater increase in rubella-specific IgG titers between acute (now) and convalescent (2-3 weeks) sera provides retrospective confirmation. 3
• Reverse transcriptase-polymerase chain reaction (RT-PCR) for rubella virus RNA from nasopharyngeal swab or throat swab provides rapid molecular confirmation. 3

Critical Laboratory Tests to Exclude Life-Threatening Causes

• Complete blood count with differential to assess for thrombocytopenia (seen in 40-94% of RMSF cases) and leukopenia (53% of RMSF). 4, 5
• Comprehensive metabolic panel to check for hyponatremia and elevated hepatic transaminases (78% of rickettsial infections). 4

Immediate Management Steps

Isolation and Public Health Notification

• Immediately isolate the patient using droplet precautions because rubella is transmitted via oral droplets and patients shed virus in the nasopharynx for approximately 7 days before and after the rash appears. 8
• Notify public health authorities immediately because rubella is a reportable disease and contact tracing is essential to identify exposed pregnant women. 1, 8
• The CDC recorded only 6 rubella cases in the most recent surveillance period, making each case epidemiologically significant. 4

Assess Vaccination Status

• Determine if the child received two doses of MMR vaccine (recommended at 12-15 months and 4-6 years). 1
• Unvaccinated or incompletely vaccinated individuals are at highest risk. 1

Identify Pregnant Contacts

• Urgently identify any pregnant women exposed to this child, particularly those in the first trimester, because maternal rubella infection during the first 11 weeks of gestation causes congenital rubella syndrome in 80-90% of cases. 8, 3
• Congenital rubella syndrome includes the classic triad of cataracts, congenital heart defects (patent ductus arteriosus, pulmonary artery stenosis), and sensorineural deafness. 1, 3

Treatment

• Treatment is entirely supportive because rubella is self-limited in children. 3
• Provide antipyretics (acetaminophen or ibuprofen) for fever control. 5
• Ensure adequate hydration. 5
• Antihistamines (cetirizine or loratadine) may be used if the rash is pruritic. 5
• No antiviral therapy is indicated or available for rubella. 3

Expected Clinical Course

• The rash typically resolves within 3 days without sequelae in otherwise healthy children. 3
• Arthralgia or polyarthritis may occur, particularly in adolescent females. 1
• Complications are rare in children but include thrombocytopenia (1 per 3,000 cases) and encephalitis (1 per 6,000 cases, more common in adults). 1

Critical Pitfalls to Avoid

• Do not dismiss posterior auricular and suboccipital lymphadenopathy as nonspecific—this combination is highly specific for rubella. 1, 2
• Do not delay public health notification because identifying exposed pregnant women is time-sensitive. 8
• Do not confuse rubella with measles—rubella is milder, lacks the "3 Cs" prodrome, and has a different lymphadenopathy pattern. 1, 6
• Do not assume vaccination status without verification—vaccine failure can occur, and some adolescents remain unvaccinated. 1
• Do not start empiric doxycycline unless RMSF cannot be excluded based on exposure history, geographic location, and presence of fever with systemic symptoms. 4

Follow-Up

• Reassess within 24-48 hours to confirm clinical improvement and rash resolution. 5
• Instruct the family to return immediately if fever persists beyond 3 days, petechiae develop, or neurologic symptoms (severe headache, altered mental status) appear. 5
• Once serologic confirmation is obtained, provide documentation for school re-entry (typically after 7 days from rash onset). 8